<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Cardiovascular research institute, Isfahan University of Medical Sciences</PublisherName>
				<JournalTitle>ARYA Atherosclerosis Journal</JournalTitle>
				<Issn>1735-3955</Issn>
				<Volume>3</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2010</Year>
					<Month>12</Month>
					<Day>08</Day>
				</PubDate>
			</Journal>
<ArticleTitle>APPLICATION OF COGNITIVE-BEHAVIORAL THERAPY FOR REDUCING ANXIETY IN CARDIAC PATIENTS</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">10106</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Zohreh</FirstName>
					<LastName>Khayyam-Nekouei</LastName>
<Affiliation>Educational Sciences and Psychology School, Khorasgan Islamic Azad University, Isfahn.</Affiliation>

</Author>
<Author>
					<FirstName>Alireza</FirstName>
					<LastName>Yousefy</LastName>
<Affiliation>Ph.D .Associate Professor, Medical Education Research Center, Isfahan University of Medical Sciences; Isfahan , Iran.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2010</Year>
					<Month>12</Month>
					<Day>04</Day>
				</PubDate>
			</History>
		<Abstract>a </Abstract>
<ArchiveCopySource DocType="pdf">https://arya.mui.ac.ir/article_10106_74105d373a71b517ed650caabb9c2cb8.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Cardiovascular research institute, Isfahan University of Medical Sciences</PublisherName>
				<JournalTitle>ARYA Atherosclerosis Journal</JournalTitle>
				<Issn>1735-3955</Issn>
				<Volume>3</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2010</Year>
					<Month>12</Month>
					<Day>08</Day>
				</PubDate>
			</Journal>
<ArticleTitle>EFFECT OF L-ARGININE SUPPLEMENTATION ON THE CONCENTRATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN A CHOLESTEROL-RICH DIET WITHDRAWAL MODEL</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">10107</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Shaghayegh</FirstName>
					<LastName>Haghjooyjavanmard</LastName>
<Affiliation>M.D. Applied Physiology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Mehdi</FirstName>
					<LastName>Nematbakhsh</LastName>
<Affiliation>Ph.D., Professor, Applied Physiology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Alireza</FirstName>
					<LastName>Monajemi</LastName>
<Affiliation>M.D., Applied Physiology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Masoud</FirstName>
					<LastName>Soleimani</LastName>
<Affiliation>Ph.D., Haematology Department, School of Medicine, Tarbiat Modares University, Tehran, Iran.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2010</Year>
					<Month>12</Month>
					<Day>04</Day>
				</PubDate>
			</History>
		<Abstract>  Abstract  INTRODUCTION: Increased serum   level of vascular endothelial growth factor (VEGF) is well-documented in   hypercholesterolemia and atherosclerosis. It is associated with   atherosclerotic lesions and is considered as a marker for endothelial   dysfunction and injury. In the present study, experiments were designed to   examine the combined effects of dietary lipid withdrawal and L-arginine   supplementation on serum VEGF concentration. methods: After 4 weeks on a   high-cholesterol diet, white male rabbits (n=22) were randomly assigned to 2   groups. The diet withdrawal (DW) group (n=11) was fed normal diet and the   L-arginine group was fed normal diet and 3% L-arginine in drinking water for   another 4 weeks. The serum levels of lipids, VEGF and L-arginine were   measured before and after 4 and 8 weeks of experiment. results: The cholesterol-rich diet induced a significant   increase in total cholesterol and LDL-cholesterol in all animals. There was   no significant difference between the groups (P&gt;0.05). After 4 weeks of   cholesterol-rich diet withdrawal, animals of the DW and the L-arginine group   had similar levels of total cholesterol and LDL-cholesterol. L-arginine   supplementation resulted in a significantly higher serum level of L arginine   in the L-arginine group than in the DW group (P&lt;0.05). After 4 weeks, no significant   difference was found between the serum level of VEGF of the two groups. By   the end of study, hypercholesterolemic diet withdrawal had apparently led to   decreases in VEGF in both groups, but the serum level of VEGF was   significantly lower in the group treated with L-arginine (P&lt;0.05). CONCLUSIONS: This study showed the synergistic effect of two   endothelial protective factors, lipid lowering by diet withdrawal and   L-arginine supplementation, on VEGF production.     Keywords: Endothelial dysfunction, atherosclerosis,   vascular endothelial growth factor (VEGF), L-arginine, diet withdrawal.</Abstract>
<ArchiveCopySource DocType="pdf">https://arya.mui.ac.ir/article_10107_c4b8bb990423f770dd7f26ff79168416.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Cardiovascular research institute, Isfahan University of Medical Sciences</PublisherName>
				<JournalTitle>ARYA Atherosclerosis Journal</JournalTitle>
				<Issn>1735-3955</Issn>
				<Volume>3</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2010</Year>
					<Month>12</Month>
					<Day>08</Day>
				</PubDate>
			</Journal>
<ArticleTitle>DO L-ARGININE AND L-NAME ALTER CORONARY VASCULAR AND AORTIC ENDOTHELIAL PERMEABILITY IN NORMAL- AND HIGH-CHOLESTEROL-FED RATS?</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">10109</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Majid</FirstName>
					<LastName>Khazaei</LastName>
<Affiliation>MD, PhD, Department of Physiology, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Elham</FirstName>
					<LastName>Haghparast</LastName>
<Affiliation>MSc. Department of Physiology, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Mohammad</FirstName>
					<LastName>Afshar</LastName>
<Affiliation>PhD. Department of Anatomy, Birjand university of medical sciences, Birjand, Iran.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2010</Year>
					<Month>12</Month>
					<Day>04</Day>
				</PubDate>
			</History>
		<Abstract>Abstract    INTRODUCTION: The objective of this study was to evaluate the effect of L-arginine (L-Arg) and L-NAME on coronary vascular and aortic endothelial permeability in normocholesterolemic (NC) and hypercholesterolemic (HC) rats.    METHODS: Forty-eight male rats were divided into NC and HC groups and each group was divided into L-Arginine-treated, L-NAME-treated and control subgroups. L-Arg (2.25%) and L-NAME (0.75 mg/ml) were dissolved in drinking water and control groups received tap water. After 8 weeks, endothelial permeability was assessed by using the Evans Blue (EB) dye method.    RESULTS: Aortic endothelial permeability was significantly higher in HC group compared to NC group (15.1±0.7 vs. 7.7±0.8 µgEB/g tissue, respectively; P&lt;0.05). L-Arg and L-NAME treatment decreased aortic endothelial permeability in HC animals (L-Arg: 8.4±0.4 &amp; L-NAME: 10.8±0.6 vs. 15.1±0.7 µgEB/g tissue, respectively; P&lt;0.05). There was no significant difference in endothelial permeability in coronary circulation between HC and NC groups and L-Arg and L-NAME did not alter endothelial permeability.    CONCLUSION: It seems that L-Arg and L-NAME have different effects on endothelial permeability based on physiological and pathological conditions and type of vessel.          Keywords: L-Arginine, L-NAME, nitric oxide, endothelium, permeability.</Abstract>
<ArchiveCopySource DocType="pdf">https://arya.mui.ac.ir/article_10109_f80b8c0b896704df03fb6525733de179.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Cardiovascular research institute, Isfahan University of Medical Sciences</PublisherName>
				<JournalTitle>ARYA Atherosclerosis Journal</JournalTitle>
				<Issn>1735-3955</Issn>
				<Volume>3</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2007</Year>
					<Month>12</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>AGE-RELATED ALTERATIONS IN LIPID PEROXIDATION AND ACTIVITIES OF ERYTHROCYTE CYTOPROTECTIVE ENZYMES IN WOMEN</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">10110</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Farshad</FirstName>
					<LastName>Amirkhizi</LastName>
<Affiliation>M.Sc., Nutritionist, Department of Nutrition and Biochemistry, School of Public Health, Tehran University of Medical Sciences (TUMS), Tehran, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Fereydoun</FirstName>
					<LastName>Siassi</LastName>
<Affiliation>Ph.D., Professor. Department of Nutrition and Biochemistry, School of Public Health, TUMS, Tehran, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Sara</FirstName>
					<LastName>Minaie</LastName>
<Affiliation>M.Sc., Nutritionist, Department of Nutrition and Biochemistry, School of Public Health, TUMS, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Mahmoud</FirstName>
					<LastName>Djalali</LastName>
<Affiliation>Ph.D., Associate Professor, Department of Nutrition and Biochemistry, School of Public Health, TUMS, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Abbas</FirstName>
					<LastName>Rahimi</LastName>
<Affiliation>Ph.D., Assistant professor, Department of Epidemiology and Public Health, School of Public Health, TUMS, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Maryam</FirstName>
					<LastName>Chamari</LastName>
<Affiliation>M.Sc., Nutritionist, Department of Nutrition and Biochemistry, School of Public Health, TUMS, Iran.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2010</Year>
					<Month>12</Month>
					<Day>04</Day>
				</PubDate>
			</History>
		<Abstract>  Abstract  INTRODUCTION: The incidence of   atherosclerosis increases with age, as do various indices of   free-radical-mediated damage, e.g. lipid peroxidation. Because Antioxidant   enzymes are the major defense system of cells in normal aerobic reactions, we   aimed to assess the age-related alterations in the activity of erythrocyte   cytoprotective enzymes among women. methods: One hundred sixty   20-45-year-old women were randomly selected among women receiving the   services of rural health centers of Kerman     Province, Iran.   Data were gathered by using questionnaires and face-to-face interviews. We   assessed lipid peroxidation by measuring the concentrations of plasma   malondialdehyde (MDA), total antioxidant capacity (TAC), and the activities   of erythrocyte copper-zinc superoxide dismutase (CuZn-SOD), glutathione   peroxidase (GPX) and catalase (CAT). results: Those individuals in the highest quartiles of age   and number of pregnancies presented the highest levels of plasma MDA   (P&lt;0.001). We also observed an inverse relationship between age and   erythrocyte CuZn-SOD and GPX activities. Although we found no significant   difference between age groups in respect of erythrocyte CAT activity and/or   plasma TAC levels, erythrocyte GPX activity was negatively correlated with   the number of pregnancies (P&lt;0.001) . No significant difference was found   between age groups and/or between quartiles of number of pregnancies for   either energy or nutrient intake. Plasma MDA levels were positively related   to age (r=0.307; P&lt;0.0001), number of pregnancies (r=0.250; P&lt;0.001),   fat intake (r=0.281; P&lt;0.05) and Vitamin E intake (r=0.356; P&lt;0.01).   Furthermore, there were negative correlations both between age and GPX   activity (r= -0.280; P&lt;0.0001) as well as with CuZn-SOD(r= -0.228;   P&lt;0.005). CONCLUSIONS: Lipid peroxidation and antioxidants were affected   by age. Erythrocyte cytoprotective enzymes have an important role in detoxification   of free radicals in the body; the age-related decrease in the activities of   these enzymes might contribute to atherogenesis, along with classic risk   factors.      Keywords: Age, lipid peroxidation, cytoprotective enzymes,   oxidative stress, women.</Abstract>
<ArchiveCopySource DocType="pdf">https://arya.mui.ac.ir/article_10110_47a85128570a3482beea9592a3cc7ffb.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Cardiovascular research institute, Isfahan University of Medical Sciences</PublisherName>
				<JournalTitle>ARYA Atherosclerosis Journal</JournalTitle>
				<Issn>1735-3955</Issn>
				<Volume>3</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2010</Year>
					<Month>12</Month>
					<Day>08</Day>
				</PubDate>
			</Journal>
<ArticleTitle>EFFECTS OF EICOSAPENTAENOIC ACID AND VITAMIN E SUPPLEMENTATION ON SERUM LIPID PROFILE, BLOOD PRESSURE, ANTIOXIDANT STATUS AND INFLAMMATORY RESPONSES IN MALE ATHLETES</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">10111</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Reza</FirstName>
					<LastName>Ghiasvand</LastName>
<Affiliation>M.Sc., Dept. of Nutrition and Biochemistry, School of Public Health and Institute of Public Health Research, Tehran University of Medical Sciences (TUMS), Tehran.</Affiliation>

</Author>
<Author>
					<FirstName>Seyed Abolghassem</FirstName>
					<LastName>Djazayery</LastName>
<Affiliation>Ph.D. Professor	Institute of Public Health Research, TUMS, 14155-6446 Poursina Street, Qods Street, Tehran, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Mahmoud</FirstName>
					<LastName>Djalali</LastName>
<Affiliation>Ph.D., D.Sc. Dept. of Nutrition and Biochemistry, School of Public Health and Institute of Public Health Research, TUMS, Tehran, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Seyed Ali</FirstName>
					<LastName>Keshavarz</LastName>
<Affiliation>Ph.D., Dept. of Nutrition and Biochemistry, School of Public Health and Institute of Public Health Research, TUMS, Tehran, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Mostafa</FirstName>
					<LastName>Hosseini</LastName>
<Affiliation>Ph.D., Dept. of Biostatistics and Epidemiology, School of Public Health and Institute of Public Health Research, TUMS, Tehran, Iran.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2010</Year>
					<Month>12</Month>
					<Day>04</Day>
				</PubDate>
			</History>
		<Abstract>  Abstract  INTRODUCTION: The relationship   between ω -3 fatty acids and surrogate circulating markers of cardiovascular   disease (CVD) risk, especially in healthy individuals remains to be   determined. We investigated the effects of Eicosapentaenoic acid (EPA)   supplementation, with or without vitamin E, on serum lipid profile,   C-reactive protein (CRP), blood pressure (BP) and total antioxidant capacity   in a sample of male athletes. methods: This randomized double blind   placebo-controlled clinical trial was conducted in 2006 on 34 apparently   healthy, well-trained male basketball players, aged 17-35 years, . Venous   blood samples were obtained between 5:00 and 6:00 p.m., after exercising for   2 hours, at the baseline and after intervention. Participants received 2 g   EPA and/or 400 IU vitamin E and/or placebo depending on their groups. For 6   weeks, eight subjects received an EPA supplement with vitamin E (group 1),   nine subjects received an EPA supplement with vitamin E placebo (group 2),   nine subjects received an EPA supplement placebo and vitamin E (group 3), and   eight subjects received an EPA supplement placebo and vitamin E placebo   (group 4). results: Significant decreases were documented in the   serum levels of total cholesterol (TC), triglycerides ( TG), LDL-C and CRP in   group1 (p&lt;0.01), in TC, TG, LDL-C, CRP, and BP in group 2 (p&lt;0.01), and   significant increase in total antioxidant capacity in group 3 (P&lt;0.05). No   significant difference was found in LDL between groups 1 and 4 (P&lt;0.05),   and in total antioxidant capacity between groups 2 and 3 (p&lt;0.001) and   groups 3 and 4 (p&lt;0.001), and in CRP level between groups 2 and 3   (P&lt;0.05). There were no significant differences in TC, TG, HDL-C and BP   between the groups after 6 weeks of intervention. CONCLUSIONS: Six weeks of EPA+ vitamin E supplementation   improved the lipid profile and reduced the CRP level, whereas six weeks of   EPA supplementation without vitamin E improved the lipid profile, but   increased CRP and BP. Six weeks of vitamin E supplementation alone increased   total plasma antioxidant capacity.     Keywords: Eicosapentaenoic acid, vitamin E, lipid,   antioxidant, inflammation, healthy men, exercise.</Abstract>
<ArchiveCopySource DocType="pdf">https://arya.mui.ac.ir/article_10111_70bb83c9272e6c4bc6e83e0a55c7c9c3.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Cardiovascular research institute, Isfahan University of Medical Sciences</PublisherName>
				<JournalTitle>ARYA Atherosclerosis Journal</JournalTitle>
				<Issn>1735-3955</Issn>
				<Volume>3</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2010</Year>
					<Month>12</Month>
					<Day>08</Day>
				</PubDate>
			</Journal>
<ArticleTitle>EFFECT OF AMLODIPINE ON BLOOD AND RENAL TISSUE CONCENTRATIONS OF ENDOTHELIN IN MALE RABBITS RECEIVING AN ATHEROGENIC DIET</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">10112</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Mustafa</FirstName>
					<LastName>Mohammadi</LastName>
<Affiliation>Ph.D. Associate Professor, Department of Physiology, Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Fariba</FirstName>
					<LastName>Mirzaei</LastName>
<Affiliation>M.Sc., Department of Physiology, Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2010</Year>
					<Month>12</Month>
					<Day>04</Day>
				</PubDate>
			</History>
		<Abstract>  Abstract  INTRODUCTION: Recent studies   indicate that endothelin-1 (ET-1) and abnormality in the transfer of calcium   ions have a role in the atherosclerosis process. Amlodipine can influence the   risk factors associated with atherosclerosis, but the possible protective   mechanisms of ET-1 are not known. We evaluated the effects of amlodipine   and/or high-cholesterol diet on blood and renal tissue concentration of   endothelin, as well as the role of ET-1 in the pathophysiology of   atherosclerosis in male New     Zealand white rabbits. methods: Thirty-six male New Zealand   white rabbits were divided into four groups: The normal control group, normal   group receiving amlodipine, high-cholesterol diet group and high-cholesterol   diet plus amlodipine group. After 8 weeks, all animals were anesthetized and   blood or tissues samples were colleted. results: Amlodipine led to significant increase in plasma   high-density lipoprotein cholesterol (HDL-C) and decrease in serum   triglyceride (TG) in the control group. The plasma level of ET-1 in the   atherosclerotic model group increased significantly compared with the control   group (p&lt;0.01). After 8 weeks of treatment with amlodipine, ET-1 levels   decreased significantly in the control group (p&lt;0.01) and high-cholesterol   diet rabbits (p&lt;0.01). Amlodipine administration significantly reduced the   tissue levels of endothelin only in high-cholesterol diet rabbits   (p&lt;0.01). Eight weeks of high-cholesterol diet (2%) did not induce any   atherosclerotic lesion in this artery, and amlodipine had no significant   effect. CONCLUSIONS: The increase of lipids and ET-1 in the renal   artery and plasma with a high-cholesterol diet is not linked to the early   stages of atherosclerotic plaque formation. Amlodipine can reduce levels of   ET-1 and lipids, but the mechanisms remain to be determined.     Keywords: Renal artery, atherosclerosis, amlodipine,   endothelin-1, experimental study.</Abstract>
<ArchiveCopySource DocType="pdf">https://arya.mui.ac.ir/article_10112_712a67567ec10c52c2b966224cf94d1e.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Cardiovascular research institute, Isfahan University of Medical Sciences</PublisherName>
				<JournalTitle>ARYA Atherosclerosis Journal</JournalTitle>
				<Issn>1735-3955</Issn>
				<Volume>3</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2010</Year>
					<Month>12</Month>
					<Day>08</Day>
				</PubDate>
			</Journal>
<ArticleTitle>THE EFFECTS OF BODY MASS INDEX CATEGORY ON EARLY OUTCOMES OF CORONARY ARTERY BYPASS GRAFT</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">10113</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Parvin</FirstName>
					<LastName>Dehbozorgi</LastName>
<Affiliation>M.Sc. Department of health education, Fatemeh Nursing and Midwifery College of Shiraz University of Medical Sciences. Shiraz, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Fariba</FirstName>
					<LastName>Ghodsbin</LastName>
<Affiliation>M.Sc. Fatemeh Nursing and Midwifery College of Shiraz University of Medical Sciences.</Affiliation>

</Author>
<Author>
					<FirstName>Mohammad</FirstName>
					<LastName>Janati</LastName>
<Affiliation>MD. Department of Surgery, Faghihi Hospital, Shiraz University of Medical Sciences.</Affiliation>

</Author>
<Author>
					<FirstName>Kamran</FirstName>
					<LastName>Aghasadeghi</LastName>
<Affiliation>MD. Department of Medicine, Nemazee Hospital, Shiraz University of Medical Sciences.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2010</Year>
					<Month>12</Month>
					<Day>04</Day>
				</PubDate>
			</History>
		<Abstract>  Abstract  INTRODUCTION: Deviation from   normal body size, particularly extreme obesity is associated with increased   postoperative morbidity and mortality. Obesity is often perceived to be a   risk factor for adverse outcomes following coronary artery surgery bypass   graft. The aim of this study was to evaluate the effect of body mass index on   the early outcomes in patients undergoing coronary artery bypass graft   (CABG). methods: In a retrospective study, 772   patients undergoing CABG between 2005 and 2006 were evaluated in shiraz university   affiliated medical centers. The patients’ body mass index (BMI) was measured   and classified as underweight, normal-weight, obese and severely obese. The   clinical data were evaluated with respect to early postoperative outcomes and   mortality. The main early outcomes were postoperative myocardial infarction,   sternal wound infection, respiratory and renal problems, atrial arrhythmia,   bleeding, longer duration of mechanical ventilation, prolonged hospital stay,   and increased operative mortality. The data were gathered using a demographic   information form and a checklist to determine the number of main early   outcomes. The forms were completed with data from the patients and their   records. The effect of BMI on the early outcomes in patients undergoing   coronary artery bypass graft (CABG) was assessed using odds ratio and the   logistic regression model. results: The results showed that of 772 patients, 13.6%,   2.6%, 75.4%, and 8.4% were obese, severely obese, normal-weight, and   underweight, respectively.. Obesity and severe obesity increased the risk of   sternal wound infection (odds ratio=9.761, P&lt;0.001 and odds ratio=34.441,   P&lt;0.001, respectively). Obesity increased the risk of atrial arrhythmia   (odds ratio=5.173, P&lt;0.001). Obesity and severe obesity were significantly   associated with respiratory problems and postoperative stay longer than 14   days. Severe obesity increased the risk of operative mortality (odds   ratio=15.390, P&lt;0.001). There was no difference between obese and severely   obese patients in respect of the incidence of myocardial infarction, renal   failure, and bleeding following operation. CONCLUSIONS: Obesity and severe obesity are associated with   increased early complications and operative mortality after CABG, and the   degree of obesity plays a key role in adverse outcomes of this procedure..   Hence, weight loss can contribute to reduction of postoperative CABG   complications and mortality.     Keywords: Body mass index, coronary artery bypass graft,   obesity, morbidity, mortality.</Abstract>
<ArchiveCopySource DocType="pdf">https://arya.mui.ac.ir/article_10113_e52ff15f1c6cff78c4e54fd19026256d.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Cardiovascular research institute, Isfahan University of Medical Sciences</PublisherName>
				<JournalTitle>ARYA Atherosclerosis Journal</JournalTitle>
				<Issn>1735-3955</Issn>
				<Volume>3</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2010</Year>
					<Month>12</Month>
					<Day>08</Day>
				</PubDate>
			</Journal>
<ArticleTitle>DEMOGRAPHIC AND MEDICAL PREDICTORS OF THE ONSET OF POST-MI DEPRESSION</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">10114</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Reza</FirstName>
					<LastName>Bagherian</LastName>
<Affiliation>Ph.D. Assistant Professor, Department of Psychiatry, Isfahan University of Medical Scienses (IUMS), Isfahan, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Hamid</FirstName>
					<LastName>Saneei</LastName>
<Affiliation>M.D. Assistant Professor, Department of Internal Medicine, School of Medicine, IUMS, Isfahan, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Hadi</FirstName>
					<LastName>Bahrami Ehsan</LastName>
<Affiliation>Ph.D., Department of Psychology, Tehran University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2010</Year>
					<Month>12</Month>
					<Day>04</Day>
				</PubDate>
			</History>
		<Abstract>  Abstract  INTRODUCTION: Depression is   common amongst post-myocardial infarction (MI) patients and it has been   associated with adverse clinical events in these patients. Post-MI depression   has also been shown to be an independent risk factor for mortality. However,   many questions about risk factors of post-MI depression remain unanswered.   The purpose of this study was to identify the medical and demographic   predictors of post-MI depression, in so far these are routinely available   during MI hospitalization. methods: 176 consecutive patients   admitted to the CCU wards following MI were selected based on the inclusion   and exclusion criteria. Baseline measures were conducted during   hospitalization using a standardized history that included questions about   demographic characteristics and medical information, and all patients were   underwent a physical examination. Severity of MI index was assessed by a   cardiologist using the Killip Class. Also CPK levels were measured on   admission and over the 2 subsequent days as additional measures of the   severity of MI. The diagnosis of depression (including major and minor   depression) at three months after MI was assessed using a standardized,   semistructured research interview by a psychiatrist and a clinical   psychologist. This interview provided DSM-IV diagnoses based on the patients’   psychiatric symptoms. results: The findings showed that 46/6% suffered from   post-MI depression three months following MI. In multivariable analysis,   beta-blocker (OR 2.987; CI 1.254-7.116), history of depressive disorders (OR   2.838; CI 1.271-6.340), log max CPK (creatinine phosphokinase value) (OR   2.410; CI 1.075-5.404), and age &lt;60 (OR 2.652; CI 1.061-6.626) were   factors significantly associated with post-MI depression. This predictive   model also yielded 74.4% maximum predictive efficiency with 67.1% sensitivity   and 80.9% specificity rates respectively, for differentiating those with and   those without high risk for developing post-MI depression. CONCLUSIONS: Beta-blocker, history of depressive disorders,   log max CPK (creatinine phosphokinase value), and age comprise demographic   and medical predictors for post-MI depressive symptoms. Thus, considering the   above model, clinicians may able to identify MI patients with a high risk for   subsequent development of depression so that these patients may be targeted   for screening and potentially for psychosocial intervention. The association   found between depression and creatinine phosphokinase (CPK) value begs the   questions why two seemingly unrelated conditions should be related, and what   mediators or common biological pathways could link the two phenomena.      Keywords: Depression, myocardial infarction, demographic   and medical predictors.</Abstract>
<ArchiveCopySource DocType="pdf">https://arya.mui.ac.ir/article_10114_0678c572b0d5597d2d4a6b5bd135754c.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Cardiovascular research institute, Isfahan University of Medical Sciences</PublisherName>
				<JournalTitle>ARYA Atherosclerosis Journal</JournalTitle>
				<Issn>1735-3955</Issn>
				<Volume>3</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2010</Year>
					<Month>12</Month>
					<Day>08</Day>
				</PubDate>
			</Journal>
<ArticleTitle>ANOMALOUS ORIGIN OF RIGHT CORONARY ARTERY FROM LEFT ANTERIOR DESCENDING ARTERY: SINGLE CORONARY ARTERY</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">10108</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Ahmadnoor</FirstName>
					<LastName>Abdi</LastName>
<Affiliation>M.D. Cardiology Department, Noor Hospital, Isfahan University of Medical Sciences (IUMS). Isfahan, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Leila</FirstName>
					<LastName>Salehizade</LastName>
<Affiliation>M.D. Cardiology Department, Noor Hospital, IUMS. Isfahan, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Rezvan</FirstName>
					<LastName>Ansari</LastName>
<Affiliation>B.Sc. Hypertension Research Unit, Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences. Isfahan, Iran.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2010</Year>
					<Month>12</Month>
					<Day>04</Day>
				</PubDate>
			</History>
		<Abstract>a</Abstract>
<ArchiveCopySource DocType="pdf">https://arya.mui.ac.ir/article_10108_cc298d5bc587e1b650f80e10449ee9d5.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
